Skip to content

Evaluation of Renal Injury After RIRS Using Shear-Wave Elastography

Assessment of Renal Parenchymal Damage Following Retrograde Intrarenal Surgery Using Shear-Wave Elastography

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07615452
Enrollment
60
Registered
2026-05-29
Start date
2026-06-01
Completion date
2026-11-01
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stone

Keywords

Retrograde intrarenal surgery, Shear-wave elastography, Kidney injury, kidney stone

Brief summary

This study aims to evaluate changes in renal parenchyma following retrograde intrarenal surgery (RIRS) using shear-wave elastography. Renal elastography measurements will be performed in patients undergoing RIRS for kidney stones on the preoperative day, on the first postoperative day, and on the seventh postoperative day. Postoperative pain scores, perioperative outcomes, stone-free status and complications will also be assessed.

Interventions

DEVICEAspiration-assisted ureteral access sheath

Patients undergoing retrograde intrarenal surgery using an aspiration-assisted ureteral access sheath

Standard ureteral access sheath used during retrograde intrarenal surgery.

Sponsors

Cengiz Canakci, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Patients undergoing RIRS for renal stones * Stone size between \< 20 mm * Negative urine culture

Exclusion criteria

* Active urinary tract infection * Congenital renal anomalies * Solitary kidney * Chronic kidney disease * Previous PCNL or open surgery * Ureteral stricture disease

Design outcomes

Primary

MeasureTime frameDescription
Renal Cortical Shear-Wave Elastography Values (kPa)Elastography assessments will be performed preoperatively, on postoperative day 1, and on postoperative day 7 to evaluate perioperative renal parenchymal changes.Renal cortical stiffness will be quantitatively evaluated using ultrasound-based shear-wave elastography. Measurements will be obtained from multiple regions of the renal cortex, and the mean value of these measurements will be recorded in kilopascals (kPa). All examinations will be performed using the same ultrasound device and standardized protocol by a single experienced radiologist blinded to the study groups.

Secondary

MeasureTime frameDescription
Postoperative ComplicationsFrom surgery to postoperative day 30Perioperative and postoperative complications assessed according to the Clavien-Dindo classification system.
Serum Creatinine LevelPreoperative baseline, postoperative day 1, and postoperative day 7Serum creatinine levels measured to evaluate renal function changes following retrograde intrarenal surgery.
Postoperative Fever and SepsisFrom surgery to postoperative day 30Occurrence of postoperative fever (\>38°C) and/or sepsis following surgery.
Stone-Free RatePostoperative month 1Stone-free status assessed by postoperative imaging.
Renal Resistive IndexPreoperative baseline, postoperative day 1 and postoperative day 7Renal resistive index values measured using Doppler ultrasonography to evaluate renal vascular resistance following retrograde intrarenal surgery.
Mayo Adhesive Probability ScorePreoperative periodPerinephric fat adhesion severity assessed using the Mayo Adhesive Probability (MAP) Score based on preoperative computed tomography findings. The MAP Score ranges from 0 to 5, with higher scores indicating a greater likelihood of adherent perinephric fat and increased surgical complexity.
Postoperative Pain Scorespreoperative, postoperative 6th hour, and postoperative 24th hour.. Postoperative pain intensity was assessed using the Visual Analogue Scale (VAS), a 10-point scale ranging from 0 to 10, where 0 indicates no pain and 10 represents the most severe pain imaginable. Higher scores indicate greater pain intensity.

Contacts

CONTACTCengiz Çanakcı
cengizcanakci@hotmail.com+905454738043

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026